2389 — Beijing Health (Holdings) Income Statement
0.000.00%
- HK$448.35m
- HK$223.09m
- HK$149.95m
Annual income statement for Beijing Health (Holdings), fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 150 | 204 | 166 | 140 | 150 |
| Cost of Revenue | |||||
| Gross Profit | 32.8 | 47 | 46.5 | 38.5 | 35.7 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 305 | 230 | 224 | 186 | 239 |
| Operating Profit | -155 | -26.7 | -57.8 | -45.4 | -88.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -201 | -46.6 | -103 | -68.8 | -119 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -200 | -40.2 | -98.8 | -61.7 | -116 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -185 | -39.4 | -97.7 | -61.9 | -116 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -185 | -39.4 | -97.7 | -61.9 | -116 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.023 | -0.009 | -0.016 | -0.01 | -0.018 |